Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.83)
# 536
Out of 4,818 analysts
230
Total ratings
64.74%
Success rate
23.22%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $664 → $563 | $435.86 | +29.17% | 16 | Apr 22, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $109.25 | +68.42% | 20 | Feb 5, 2025 | |
| LH Labcorp Holdings | Maintains: Overweight | $260 → $270 | $224.98 | +20.01% | 15 | Dec 17, 2024 | |
| DOCS Doximity | Upgrades: Equal-Weight | $33 → $53 | $54.63 | -2.98% | 9 | Nov 14, 2024 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $6.38 | +56.86% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $4.65 | +18.28% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $12.14 | -38.22% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $18.33 | -34.53% | 8 | Aug 30, 2023 | |
| CNC Centene | Downgrades: Equal-Weight | $94 → $73 | $62.37 | +17.04% | 10 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $172.64 | -16.01% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $329.22 | +10.87% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $688.10 | -38.96% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $8.05 | +1,390.68% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $264.54 | +134.37% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $430.23 | +16.22% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $65.64 | +88.91% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $335.21 | -5.13% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $134.78 | -48.06% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $11.01 | +254.22% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $148.11 | +31.66% | 6 | Oct 21, 2020 |
UnitedHealth Group
Apr 22, 2025
Maintains: Overweight
Price Target: $664 → $563
Current: $435.86
Upside: +29.17%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $109.25
Upside: +68.42%
Labcorp Holdings
Dec 17, 2024
Maintains: Overweight
Price Target: $260 → $270
Current: $224.98
Upside: +20.01%
Doximity
Nov 14, 2024
Upgrades: Equal-Weight
Price Target: $33 → $53
Current: $54.63
Upside: -2.98%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.38
Upside: +56.86%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $4.65
Upside: +18.28%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $12.14
Upside: -38.22%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $18.33
Upside: -34.53%
Centene
Aug 30, 2023
Downgrades: Equal-Weight
Price Target: $94 → $73
Current: $62.37
Upside: +17.04%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $172.64
Upside: -16.01%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $329.22
Upside: +10.87%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $688.10
Upside: -38.96%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $8.05
Upside: +1,390.68%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $264.54
Upside: +134.37%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $430.23
Upside: +16.22%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $65.64
Upside: +88.91%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $335.21
Upside: -5.13%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $134.78
Upside: -48.06%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.01
Upside: +254.22%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $148.11
Upside: +31.66%